Ivan Kuznetsov
53 posts

Ivan Kuznetsov
@IvanKuznet
Cards fellow @UCSFCardiology || Prev IM resident @PennIMResidents & MD/PhD @PennMedicine @pennbioeng || Engineered biology to study metabolic disease.



Big #RegenerativeMedicine advance! New study demonstrates the use of iPSC-heart muscle to treat a patient with heart failure. The patches successfully engrafted, contributing to heart repair. Patient survived 3 months before receiving a heart transplant nature.com/articles/s4158…








Light-regulated TurboID, or LOV-Turbo, is a feat of engineered allostery, created by @SongyiLee10 and @CheahJoleen via structure-guided design, then optimized by yeast display directed evolution. Activity is nearly undetectable in the dark state, but increases within seconds to a level comparable to TurboID after weak blue-light illumination. Removing light shuts LOV-Turbo off again (ie, it is reversible). LOV-Turbo is easy to use in mammalian cells, yeast, bacteria, and even in the mouse brain to suppress background labeling from endogenous biotin, to perform pulse-chase proteomics, and to spatially control biotinylation. We also show that instead of external blue light, LOV-Turbo can be activated by genetically-encoded light, ie bioluminescence from luciferase, via BRET (Figure 4F-I). Huge thanks to incredibly talented co-first authors @SongyiLee10 and @CheahJoleen, and our wonderful collaborators Steve Carr and @namude. Also many thanks to co-authors @Simenzhao, Charles Wu, @heegwangroh, @tinakim_neuro and @kelvinfcho for their contributions. Plasmids will be available on Addgene in the near future! biorxiv.org/cgi/content/sh…









Our latest! We “found” a protein that *both* clusters AND binds the plasma membrane in response to blue light. But actually it was in front of us the whole time. Work led by Ayush Aditya Pal and Will Benman. A🧵. biorxiv.org/content/10.110…








